A scene from Cosmo Pharmaceuticals' manufacturing plant in Lainate, Italy. Cosmo Pharmaceuticals says it plans to file for FDA approval of its androgenetic alopecia (AGA) candidate clascoterone 5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results